Annual CFF
$13.58 M
+$6.05 M+80.33%
December 31, 2023
Summary
- As of February 20, 2025, PXMD annual cash flow from financing activities is $13.58 million, with the most recent change of +$6.05 million (+80.33%) on December 31, 2023.
- During the last 3 years, PXMD annual CFF has risen by +$10.13 million (+293.83%).
- PXMD annual CFF is now at all-time high.
Performance
PXMD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
+$15.30 K+100.00%
June 1, 2024
Summary
- As of February 20, 2025, PXMD quarterly cash flow from financing activities is $0.00, with the most recent change of +$15.30 thousand (+100.00%) on June 1, 2024.
- Over the past year, PXMD quarterly CFF has stayed the same.
- PXMD quarterly CFF is now -100.00% below its all-time high of $7.13 million, reached on September 30, 2022.
Performance
PXMD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$6.57 M
-$1.92 M-22.60%
June 1, 2024
Summary
- As of February 20, 2025, PXMD TTM cash flow from financing activities is $6.57 million, with the most recent change of -$1.92 million (-22.60%) on June 1, 2024.
- Over the past year, PXMD TTM CFF has stayed the same.
- PXMD TTM CFF is now -51.58% below its all-time high of $13.58 million, reached on December 31, 2023.
Performance
PXMD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PXMD Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +80.3% | 0.0% | 0.0% |
3 y3 years | +293.8% | +100.0% | -15.3% |
5 y5 years | - | +100.0% | -15.3% |
PXMD Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +180.9% | -100.0% | +100.0% | -51.6% | +4039.3% |
5 y | 5-year | at high | +3021.2% | -100.0% | +100.0% | -51.6% | +4039.3% |
alltime | all time | at high | +3021.2% | -100.0% | +100.0% | -51.6% | +4039.3% |
PaxMedica Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2024 | - | $0.00(-100.0%) | $6.57 M(-22.6%) |
Mar 2024 | - | -$15.30 K(-100.2%) | $8.49 M(-37.4%) |
Dec 2023 | $13.58 M(+80.3%) | $6.17 M(+1388.3%) | $13.58 M(+99.4%) |
Sep 2023 | - | $414.90 K(-78.4%) | $6.81 M(-49.6%) |
Jun 2023 | - | $1.92 M(-62.1%) | $13.52 M(+7.3%) |
Mar 2023 | - | $5.07 M(-952.6%) | $12.60 M(+67.3%) |
Dec 2022 | $7.53 M(+55.8%) | -$594.40 K(-108.3%) | $7.53 M(-6.1%) |
Sep 2022 | - | $7.13 M(+614.6%) | $8.02 M(+865.6%) |
Jun 2022 | - | $997.20 K(>+9900.0%) | $830.30 K(-597.5%) |
Mar 2022 | - | $0.00(-100.0%) | -$166.90 K(-103.5%) |
Dec 2021 | $4.83 M | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | - | -$106.10 K(+74.5%) | $4.83 M(-37.8%) |
Sep 2021 | - | -$60.80 K(<-9900.0%) | $7.77 M(-2.0%) |
Jun 2021 | - | $0.00(-100.0%) | $7.93 M(-1.9%) |
Mar 2021 | - | $5.00 M(+76.8%) | $8.08 M(+134.3%) |
Dec 2020 | $3.45 M(+692.5%) | $2.83 M(+2727.5%) | $3.45 M(+456.0%) |
Sep 2020 | - | $100.00 K(-33.3%) | $620.00 K(+19.2%) |
Jun 2020 | - | $150.00 K(-59.5%) | $520.00 K(+5.1%) |
Mar 2020 | - | $370.00 K(+196.0%) | $495.00 K(+120.0%) |
Dec 2019 | $435.00 K | - | - |
Jun 2019 | - | $125.00 K(+25.0%) | $225.00 K(+125.0%) |
Mar 2019 | - | $100.00 K | $100.00 K |
FAQ
- What is PaxMedica annual cash flow from financing activities?
- What is the all time high annual CFF for PaxMedica?
- What is PaxMedica annual CFF year-on-year change?
- What is PaxMedica quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for PaxMedica?
- What is PaxMedica quarterly CFF year-on-year change?
- What is PaxMedica TTM cash flow from financing activities?
- What is the all time high TTM CFF for PaxMedica?
- What is PaxMedica TTM CFF year-on-year change?
What is PaxMedica annual cash flow from financing activities?
The current annual CFF of PXMD is $13.58 M
What is the all time high annual CFF for PaxMedica?
PaxMedica all-time high annual cash flow from financing activities is $13.58 M
What is PaxMedica annual CFF year-on-year change?
Over the past year, PXMD annual cash flow from financing activities has changed by +$6.05 M (+80.33%)
What is PaxMedica quarterly cash flow from financing activities?
The current quarterly CFF of PXMD is $0.00
What is the all time high quarterly CFF for PaxMedica?
PaxMedica all-time high quarterly cash flow from financing activities is $7.13 M
What is PaxMedica quarterly CFF year-on-year change?
Over the past year, PXMD quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is PaxMedica TTM cash flow from financing activities?
The current TTM CFF of PXMD is $6.57 M
What is the all time high TTM CFF for PaxMedica?
PaxMedica all-time high TTM cash flow from financing activities is $13.58 M
What is PaxMedica TTM CFF year-on-year change?
Over the past year, PXMD TTM cash flow from financing activities has changed by $0.00 (0.00%)